The SDS Poly Acrylamide Gel Electrophoresis Market is likely to scintillate going forward. With various cloud options to explore, the healthcare industry is expected to be at a newer high in the forecast period. In other words, organizations across the globe are advancing their downtime regarding digital business initiatives. They are swiftly moving towards the cloud for modernizing the environments, enhancing system reliability, supporting hybrid work models, and addressing the other new-fangled realities surfacing in recent times. This would be the outlook of the healthcare vertical in the upcoming period.
The global SDS poly acrylamide gel electrophoresis (PAGE) market is set to exhibit a promising 5% CAGR during the forecast period (2019 – 2029). Introduction of 2D and 3D electrophoresis techniques has increased the sensitivity and reproducibility of SDS poly acrylamide gel electrophoresis.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11629
Besides, the recent evolution of automated electrophoresis using microfluidics technology has attained a high level of reliability, resolution, and accuracy. It has reduced hands-on time and offers results for any protein analysis. Consequently, the key market leaders around the globe are now focusing on continuous investments towards the development of advanced SDS poly acrylamide gel electrophoresis products.
Increasing research funding for drug development in North America region is expected to provide lucrative opportunities. For instance, according to the report by the Council of Economic Advisers, in 2018, the U.S. funded approximately 50% of the world’s medical research and development programs.
- Bio-Rad Laboratories, Inc.
- General Electric Company (GE Healthcare)
- Merck KGaA (Sigma Aldrich)
- Thermo Fisher Scientific Inc.
- Analytik Jena AG (Endress+Hauser AG)
- Lonza Group Ltd
- Genscript Biotech Corporation
- Abcam Plc
- TAKARA BIO INC.
- Cleaver Scientific Ltd.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11629
Key Takeaways – SDS Poly Acrylamide Gel Electrophoresis Market Study
- Market players are focusing on offering innovative products of SDS poly acrylamide gel electrophoresis to deliver better protein separation.
- In September 2015, Cleaver Scientific introduced its new horizontal polyacrylamide gel electrophoresis (hPAGE) system in collaboration with the Kirkhouse Trust, which allows to run large number of samples simultaneously with greater resolution.
- Acquisitions and collaborations are the key strategies adopted by these leading manufacturers to develop technologically advanced products for proteomic research and enhance their product portfolio.
- For instance, in January 2013, Merck KGaA, a German multinational pharmaceutical, acquired Bangalore Genei (India) Pvt. Ltd. (BGIP), which specializes in new generation proteomic and genomic research technologies and cutting-edge study of proteins and organisms.
- North America holds a significant market share of 35% in 2019 owing to a paradigm shift towards drug discovery where a lot of research work are being carried out also at academic institutes besides clinical research organization.
Increased investment in life science products and incessant demand for customized tools and reagents in proteomic research for drug discovery will significantly fuel demand for SDS poly acrylamide gel electrophoresis in the near future.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/11629
Competitive Analysis Reveals Buzz Around Investments
The SDS poly acrylamide gel electrophoresis market report tracks the key market players operating in the global SDS poly acrylamide gel electrophoresis market, which include Bio-Rad Laboratories, Inc., Merck KGaA (Sigma Aldrich), General Electric Company (GE Healthcare), Thermo Fisher Scientific Inc., Lonza Group Ltd. and Analytik Jena AG (Endress+Hauser AG), Genscript Biotech Corporation, Abcam Plc., TAKARA BIO INC., and Cleaver Scientific Ltd.
Leading manufacturers of SDS poly acrylamide gel electrophoresis are focusing on strategic investment to enhance their product portfolio. In October 2019, Arranta Bio announces $82M funding and strategic venture with Thermo Fisher Scientific for the development and manufacturing of biopharmaceutical products.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on SDS poly acrylamide gel electrophoresis in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 on the basis of product type (instruments, reagents and gels), and end user (clinical research, biotechnology and pharmaceutical industry, government agencies, academic institutes) in five key regions.
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com